264 related articles for article (PubMed ID: 37292204)
1. The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment.
Zhang Y; Dong P; Yang L
Front Immunol; 2023; 14():1189323. PubMed ID: 37292204
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy.
Ma H; Xiong L; Zhao B; Hahan Z; Wei M; Shi H; Yang S; Ren Q
Front Immunol; 2024; 15():1364082. PubMed ID: 38562924
[TBL] [Abstract][Full Text] [Related]
3. Translational research in head and neck cancer: Molecular and immunological updates.
Kumai T; Shinomiya H; Shibata H; Takahashi H; Kishikawa T; Okada R; Fujieda S; Sakashita M
Auris Nasus Larynx; 2024 Apr; 51(2):391-400. PubMed ID: 37640594
[TBL] [Abstract][Full Text] [Related]
4. Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma.
Lin C; Chu Y; Zheng Y; Gu S; Hu Y; He J; Shen Z
Front Immunol; 2024; 15():1337129. PubMed ID: 38650924
[TBL] [Abstract][Full Text] [Related]
5. Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.
Ausoni S; Boscolo-Rizzo P; Singh B; Da Mosto MC; Spinato G; Tirelli G; Spinato R; Azzarello G
Cancer Metastasis Rev; 2016 Sep; 35(3):413-26. PubMed ID: 27194534
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived extracellular vesicles in the immune microenvironment of head and neck squamous cell carcinoma: Foe or future?
Xu Q; Li X
J Stomatol Oral Maxillofac Surg; 2023 Dec; 125(4):101738. PubMed ID: 38097013
[TBL] [Abstract][Full Text] [Related]
7. The changing therapeutic landscape of head and neck cancer.
Cramer JD; Burtness B; Le QT; Ferris RL
Nat Rev Clin Oncol; 2019 Nov; 16(11):669-683. PubMed ID: 31189965
[TBL] [Abstract][Full Text] [Related]
8. B cells in head and neck squamous cell carcinoma: current opinion and novel therapy.
Guo X; Xu L; Nie L; Zhang C; Liu Y; Zhao R; Cao J; Tian L; Liu M
Cancer Cell Int; 2024 Jan; 24(1):41. PubMed ID: 38245714
[TBL] [Abstract][Full Text] [Related]
9. New perspectives on biology, disease progression, and therapy response of head and neck cancer gained from single cell RNA sequencing and spatial transcriptomics.
Heller G; Fuereder T; Grandits AM; Wieser R
Oncol Res; 2023; 32(1):1-17. PubMed ID: 38188682
[TBL] [Abstract][Full Text] [Related]
10. The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites.
Wondergem NE; Nauta IH; Muijlwijk T; Leemans CR; van de Ven R
Curr Oncol Rep; 2020 Jun; 22(8):81. PubMed ID: 32602047
[TBL] [Abstract][Full Text] [Related]
11. Integrating bulk and single-cell data to predict the prognosis and identify the immune landscape in HNSCC.
Yang C; Cheng X; Gao S; Pan Q
J Cell Mol Med; 2024 Jan; 28(1):e18009. PubMed ID: 37882107
[TBL] [Abstract][Full Text] [Related]
12. Stroma modulation of radiation response in head and neck squamous cell carcinoma: Insights from zebrafish larvae xenografts.
Wahbi W; Awad S; Salo T; Al-Samadi A
Exp Cell Res; 2024 Feb; 435(1):113911. PubMed ID: 38182078
[TBL] [Abstract][Full Text] [Related]
13. The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma.
Weed DT; Zilio S; McGee C; Marnissi B; Sargi Z; Franzmann E; Thomas G; Leibowitz J; Nicolli E; Arnold D; Bicciato S; Serafini P
Cancer Res; 2023 Dec; 83(23):3886-3900. PubMed ID: 37602821
[TBL] [Abstract][Full Text] [Related]
14. Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma.
Chimote AA; Lehn MA; Bhati J; Mascia AE; Sertorio M; Lamba MA; Ionascu D; Tang AL; Langevin SM; Khodoun MV; Wise-Draper TM; Conforti L
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473367
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in patient-derived tumor organoids for reconstructing TME of head and neck cancer.
Chen L; Chen Y; Ge L; Zhang Q; Meng J
J Oral Pathol Med; 2024 Apr; 53(4):238-245. PubMed ID: 38561906
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression.
Buruiană A; Gheban BA; Gheban-Roșca IA; Georgiu C; Crișan D; Crișan M
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730679
[TBL] [Abstract][Full Text] [Related]
17. IL-1/IL-1R Signaling in Head and Neck Cancer.
Niklander SE; Murdoch C; Hunter KD
Front Oral Health; 2021; 2():722676. PubMed ID: 35048046
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer.
Economopoulou P; Kotsantis I; Psyrri A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33203092
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment - Unknown niche with powerful therapeutic potential.
Kolenda T; Przybyła W; Kapałczyńska M; Teresiak A; Zajączkowska M; Bliźniak R; Lamperska KM
Rep Pract Oncol Radiother; 2018; 23(3):143-153. PubMed ID: 29760589
[TBL] [Abstract][Full Text] [Related]
20. Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy.
Xu S; Wang Q; Ma W
Cytokine Growth Factor Rev; 2024 Apr; 76():12-21. PubMed ID: 38431507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
